Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 8/20 | 0.49 |
| ▸ | CTSS | P25774 | 4/20 | 0.49 |
| ▸ | PPARG | P37231 | 8/20 | 0.48 |
| ▸ | PPARA | Q07869 | 8/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | PPARD | Q03181 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11136103 | 0.97 | CTSK (0.47) | CTSKCTSSPPARGPPARACYP1A2 | |
| SCHEMBL13855559 | 0.95 | CTSK (0.47) | CTSKCTSSPPARGPPARACYP1A2 | |
| SCHEMBL10692756 | 0.92 | PPARA (0.50) | CTSKCTSSPPARGPPARACYP1A2 | |
| SCHEMBL5351802 | 0.88 | PPARA (0.57) | CTSKCTSSPPARGPPARACYP1A2 | |
| SCHEMBL432222 | 0.88 | PPARA (0.57) | CTSKCTSSPPARGPPARACYP1A2 | |
| SCHEMBL316084 | 0.88 | PPARA (0.57) | CTSKCTSSPPARGPPARACYP1A2 | |
| SCHEMBL2541324 | 0.88 | PPARA (0.57) | CTSKCTSSPPARGPPARACYP1A2 | |
| SCHEMBL13489723 | 0.88 | PPARA (0.57) | CTSKCTSSPPARGPPARACYP1A2 | |
| SCHEMBL7430468 | 0.87 | PPARG (0.55) | CTSKCTSSPPARGPPARACYP1A2 | |
| SCHEMBL19710006 | 0.87 | CTSK (0.51) | CTSKCTSSPPARGPPARACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6187905-B1 | PEPTIDE COMPOUND WHICH INHIBITS VIRAL PROTEINASES; VIRICIDES FOR HEPATITIS C, HEPATITIS G, AND HUMAN GB VIRUSES | HOFFMANN-LA ROCHE INC. | 2001-02-13 | — | — | US | disclosed |
| US-4764590-A | Des-19-leucine, 20-glutamine, 21-threonine-calcitonin | RORER PHARMACEUTICAL CORPORATION (US) | 1988-08-16 | — | — | US | disclosed |
| US-4622387-A | 8-methionine calcitonin | ARMOUR PHARMACEUTICAL CO. (US) | 1986-11-11 | — | — | US | disclosed |
| US-4622388-A | POLYPEPTIDES | ARMOUR PHARMACEUTICAL COMPANY (US) | 1986-11-11 | — | — | US | disclosed |
| US-4605515-A | Calcitonin-(1-23)-peptide amide | ARMOUR PHARMACEUTICAL COMPANY (US) | 1986-08-12 | — | — | US | disclosed |
| US-4497731-A | HORMONES | ARMOUR PHARMACEUTICAL COMPANY (US) | 1985-02-05 | — | — | US | disclosed |
| US-4497732-A | HORMONES | ARMOUR PHARMACEUTICAL COMPANY (US) | 1985-02-05 | — | — | US | disclosed |
| US-4495097-A | Des-serine2 -glycine8 calcitonin | ARMOUR PHARMACEUTICAL COMPANY (US) | 1985-01-22 | — | — | US | disclosed |
| US-4469632-A | REDUCTION OF SERUM CALCIUM CONCENTRATION | ARMOUR PHARMACEUTICAL COMPANY (US) | 1984-09-04 | — | — | US | disclosed |
| US-4451395-A | REDUCING SERUM CALCIUM LEVELS | ARMOUR PHARMACEUTICAL COMPANY (US) | 1984-05-29 | — | — | US | disclosed |
| US-4444681-A | L-Tyrosine21 calcitonin | ARMOUR PHARMACEUTICAL COMPANY (US) | 1984-04-24 | — | — | US | disclosed |
| US-4391747-A | CALCITONIN PEPTIDES | ARMOUR PHARMACEUTICAL COMPANY (US) | 1983-07-05 | — | — | US | disclosed |
| US-4212795-A | TO FORM DISULFIDE BOND | ARMOUR PHARMACEUTICAL COMPANY (US) | 1980-07-15 | — | — | US | disclosed |
| US-4062815-A | DIVINYLBENZENE CROSSLINKED POLYSTYRENE | ARMOUR PHARMACEUTICAL COMPANY (US) | 1977-12-13 | — | — | US | disclosed |